RBA holds at 4.35%, retains neutral bias, suggests little tolerance for upside inflation surprise
Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses the cash rate.
Read More
AMP has a long history of helping our customers manage their finances and achieve their goals.
We were founded 170 years ago on a simple yet bold idea: that financial security enabled people to live with dignity. Our founding purpose was captured by the Latin motto: Amicus Certus In Re Incerta – A sure friend in uncertain times. This deep commitment to helping clients continues and is articulated in our purpose statement today – Realise human ambitions.
A leader in the Australian market, our reach now spans around the world, where we use our expertise to help clients in New Zealand, and across Asia, the Middle East, Europe, the United Kingdom and North America
Fund Manager Chris Pedersen talks about where to look for growth, looks at ASX100 Aug winners and ASX100 Aug losers, and takes a look at AMP (ASX:AMP), Woodside (ASX:WDS) and GUD Holdings (ASX:GUD).
WATCH VIDEODr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses the cash rate.
Read More
Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses seasonal patterns in shares.
Read More
Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and Australian economic events.
Read More
Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses home prices.
Read More
Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses happiness and whether economics is failing us with its focus on GDP and consumption.
Read More
Neutral (High Risk) and $1.25 target retained for now.
Read More
Having initially retained an Underperform rating after a first galance at AMP's result yesterday, Macquaire has now decided to upgrade to Neutral. Target rises to $1.45 from $1.30.
Read More
Citi analysts remain of the view that the optimum strategy for the AMP board to release value for shareholders is through spinning off some of the divisions. Neutral/High risk rating remains in place while the price target has improved to $1.60 from $1.55.
Read More
AMP has received final regulatory approval for the sale of the life business. Macquarie estimates this leaves AMP with around $950m in excess capital.
Read More
AMP has withdrawn 2020 guidance, but the sale of Life and NZ is progressing. The broker has marked to market for funds under management but also adjusted remediation assumptions (80% already paid) to remove some duplication of earlier numbers.
Read More